FDMT 4D Molecular Therapeutics: Company Long-Term Debts

Public company logo of 4dmoleculartherapeutics.com (FDMT)

4D Molecular Therapeutics develops advanced treatments for the heart and eyes, leveraging unique patents for immune evasion. The company is actively advancing clinical trials for innovative drugs. This chart on GURU.Markets shows that long-term debt stands at 0.04. Business stability is further supported by strict temperature control during the transport of biomaterials, ensuring therapy safety for patients.

FDMT 4dmoleculartherapeutics.com Company Long-Term Loans and Borrowings (07/04/2022 - 10/31/2026)

Financial and market metric breakdowns for 4D Molecular Therapeutics Inc (FDMT)

- market price and analyst price targets:
Stock Price 4dmoleculartherapeutics.com|FDMT - Broker Consensus Forecast
- company stock capitalization data:
Market Capitalization 4D Molecular Therapeutics|FDMT - Business Value
- book value of equity indicators:
Accounting Value per Share 4D Molecular Therapeutics|FDMT - Accounting Value of Company|Market Value to Book Value Ratio 4dmoleculartherapeutics.com|FDMT - Cumulative Company Assets
- debt and liquidity data:
Debt to Equity 4D Molecular Therapeutics|FDMT - Long-Term Liabilities to Capital|Short-Term Debt to Equity 4D Molecular Corp|FDMT - Company Debts|Debts to Book Capitalization 4D Molecular Therapeutics|FDMT - Long-Term Debt|Company Short-Term Debts 4D Molecular Therapeutics|Quick Liquidity Indicator 4dmoleculartherapeutics.com
- earnings and multiples data:
FDMT - Net Profit
Analysis of all company metrics:FDMT (4dmoleculartherapeutics.com)
Manufactured products of 4D Molecular Corp

4D Molecular Therapeutics maintains a strong position in the gene therapy sector thanks to its innovative vector platform. This metric measures the aggregate of credit obligations with a maturity of over one year, determining financial stability and the cost of borrowed capital. Analyzing the organization's long-term debt level allows for an assessment of the resources available to conduct costly clinical trials in the US. The stable trend of this indicator confirms the company's ability to scale development without a critical risk of default.

Direct competitors

Company Long-Term Debts Tempus Labs TEM|Qiagen (QGEN) - Company Long-Term Indebtedness|IONS - Company Long-Term Debts|Company Long-Term Indebtedness Repligen Corp.|Company Long-Term Liabilities Avidity Corp|CRSP - Company Long-Term Loans and Borrowings|Company Long-Term Debt WGS|Company Long-Term Liabilities RARE (Ultragenyx)|Company Long-Term Debt BEAM (Beam Therapeutics Inc)|SRPT: Long-Term Debt|Twist Bioscience Corp - Company Long-Term Debt|TXG - Company Long-Term Debt|NTLA - Company Long-Term Debts|Long-Term Debt STOK|BioLife Solutions Inc (BLFS) - Company Long-Term Debts|Company Long-Term Liabilities WVE|Company Long-Term Liabilities Maze Therapeutics Corp (MAZE)|Company Long-Term Debts SION|Company Long-Term Debt PRME (primemedicine.com)|Company Long-Term Debt Taysha Gene Therapies, Inc. TSHA|Company Long-Term Debts uniQure NV QURE|MeiraGTx PLC - Company Long-Term Debts|RGNX: Company Long-Term Debt|Company Long-Term Loans and Borrowings Solid Biosciences Inc. SLDB|Company Long-Term Liabilities ocugen.com|PACB - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities Benitec Biopharma Inc (BNTC)|Amount of Long-Term Liabilities Design Pharma|Company Long-Term Debts Rocket Corp (RCKT)|Company Long-Term Loans and Borrowings Lexeo Therapeutics, Inc.|Company Long-Term Debts Korro Bio Inc. KRRO|EDIT (Editas Medicine) - Long-Term Debt|SLN: Company Long-Term Debt|Company Long-Term Loans and Borrowings proqr.com PRQR|Codexis (CDXS) - Company Long-Term Debts|SGMO (Sangamo Therapeutics) - Company Long-Term Debts|Company Long-Term Debt NAUT|MGX - Long-Term Liabilities|Company Long-Term Debts Precision BioSciences Inc. (DTIL)|GBIO: Long-Term Debt|BOLD - Company Long-Term Liabilities|Exicure Corp - Company Long-Term Debts|Imunon, Inc. (IMNN) - Company Long-Term Liabilities|PHIO - Amount of Long-Term Liabilities|Mustang Bio (MBIO) - Company Long-Term Debts|RNAZ: Long-Term Debt Volume|Company Long-Term Debts Bionano|Company Long-Term Liabilities APDN (Applied DNA Sciences)|Company Long-Term Debt BLUE (bluebirdbio.com)|Long-Term Debt Volume IPA|Company Long-Term Debts Omega Therapeutics Inc OMGA|Long-Term Liabilities Singular Genomics Systems Inc|RGLS - Company Long-Term Debts|Company Long-Term Indebtedness Syros Pharmaceuticals|TBIO (telesisbio.com) - Company Long-Term Debt|Company Long-Term Liabilities TCON|Company Long-Term Liabilities Unity Biotechnology Inc. (UBX)